参考文献/References:
[1]BATASH R, ASNA N, SCHAFFER P, et al. Glioblastoma multiforme,diagnosis and treatment: recentl iterature review[J]. Curr Med Chem, 2017, 24(27): 3002-3009.
[2]MA QQ, LONG WY, XING CS, et al. Cancer stem cells and immuno suppressive microen-vironment in glioma [J].Front Immunol, 2018, 9: 2924.
[3]GIERYNG A, PSZCZOLKOWSKA D, WALENTYNOWICZ KA, et al. Immune microenvironment of gliomas [J].Lab Invest, 2017, 97: 498-518.
[4]GIOTTA LUCIFERO A, LUZZI S, BRAMBILLA I, et al.Innovative therapies for malignant brain tumors: the road to a tailored cure [J]. Acta Biomed, 2020, 91(7-S): 5-17.
[5]REINACAMPOS M, MOSCAT J, DIAZ-MECO M. Metabolism shapes the tumor microenvironment [J]. Curr Opin Cell Biol, 2017, 48: 47-53.
[6]CHEN Z, HAMBARDZUMYAN D. Immune microenvironment in glioblastoma subtypes [J]. Front Immunol, 2018, 9:1004.
[7]PERNG P, LIM M. Immunosuppressive mechanisms ofmalignant gliomas：parallel 8 at non-CNS sites [J]. Front 0ncol, 2015, 5: 153.
[8]PRINZ M, PRILLER J. The role of peripheral immune cells in the CNS in steady state and disease [J]. Nat Neumsci, 2017, 20: 136-144.
[9]PYONTECK SM, AKKARI L, SCHUHMACHER AJ, et al.CSF-1R inhibition alters macrophage polarization and blocks glioma progression [J]. Nat Med, 2013, 19(10): 1264-1272.
[10]BRANDENBURG S, MüLLER A, TURKOWSKI K, et al.Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors [J]. Acta Neuropathol,2016, 131(3): 365-378.
[11]TERRéN I, ORRANTIA A, VITALLé J, et al. NK cellmetabolism and tumor microenvironment [J]. Front Immunol, 2019, 10: 2278.
[12]HASMIM M, NOMAN MZ, MESSAI Y, et al. Cutting edge: hypoxia-induced nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1 [J]. J Immunol, 2013, 191(12): 5802-5806.
[13]ZHAO E, MAJ T, KRYCZEK I, et al. Cancer mediateseffector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction [J]. Nat Immunol, 2016,17(1): 95-103.
[14]FU X, LIU G, HALIM A, et al. Mesenchymal stem cellmigration and tissue repair [J]. Cells, 2019, 8(8): 784.
[15]GALIPEAU J, SENSéBé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities [J]. Cell Stem Cell, 2018, 22(6): 824-833.
[16]JI M, WANG W, LI S, et al. Implantation of bone esenchymal stem cells overexpressing miRNA-705 mitigated ischemic brain injury [J]. Mol Med Rep, 2017, 16(6): 8323-8328.
[17]ZHONG W, TONG Y, LI Y, et al. Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NFκB signaling by paracrine CCL5 [J]. Oncotarget, 2017, 8(43): 73693-73704.
[18]LIN HD, FONG CY, BISWAS A, et al. Human umbilical cord Wharton's Jelly stem cell conditioned medium induces tumoricidal effects on lymphoma cells through hydrogen peroxide mediation [J]. J Cell Biochem, 2016, 117(9): 2045-2055.
[19]KABAT M, BOBKOV I, KUMAR S, et al. Trends in mesenchymal stem cell clinical trials 2004-2018: is efficacy optimal in a narrow dose range [J]? Stem Cells Transl Med,2020, 9(1): 17-27.
[20]COLEGIO OR, CHU NQ, SZABO AL, et al. Functionalpolarization of tumour-associated macrophages by tumourderived lactic acid [J]. Nature, 2014, 513(7519): 559-563.
[21]YAO P, ZHOU L, ZHU L, et al. Mesenchymal stem cells: apotential therapeutic strategy for neurodegenerative diseases[J]. Eur Neurol, 2020, 83(3): 235-241.
[22]HUSE JT, HOLLAND EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma [J]. Nat Rev Cancer, 2010, 10(5): 319-331.
[23]ZHANG Q, XIANG W, YI DY, et al. Current status andpotential challenges of mesenchymal stem cell-based therapy for malignant gliomas [J]. Stem Cell Res Ther, 2018, 9(1): 228.
[24]RAZAVI SM, LEE KE, JIN BE, et al. Immune evasion strategies of glioblastoma [J]. Front Surg, 2016, 3: 11.
[25]SHERMAN LS, ROMAGANO MP, WILLIAMS SF, et al. Mesenchymal stem cell therapies in brain disease [J]. Semin Cell Dev Biol, 2019, 95: 111-119.
[26]BOVENBERG MS, DEGELING MH, TANNOUS BA.Advances in stem cell therapy against gliomas [J]. Trends Mol Med, 2013, 19(5): 281-291.
[27]MARTINEZ-QUINTANILLA J, HE D, WAKIMOTO H, et al. Encapsulated stem cells loaded with hyaluronidaseexpressing oncolytic virus for brain tumor therapy [J]. Mol Ther, 2015, 23(1): 108-118.
[28]WANG Q, ZHANG Z, DING T, et al. Mesenchymal stem cells overexpressing PEDF decrease the angiogenesis of gliomas [J]. Biosci Rep, 2013, 33(2): e00019.
[29]KATAKOWSKI M, BULLER B, ZHENG X. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth [J]. Cancer Lett, 2013, 335(1): 201-204.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(10):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(10):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(10):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(10):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(10):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(10):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(10):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(10):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]